D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the utility of post-session administration of
D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be
treated with CBT.